Certain information that is included in this investor presentation may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission.

Cautionary Statement Regarding Forward-Looking Information

Company Overview

• Formed in 1996

• Leading marketer of pet medications and other health products for dogs and cats direct to the consumer.

• Markets its products through national advertising campaigns, which direct the consumer to order by phone or on the internet, and aim to increase recognition of the "1-800-PetMeds" brand name.

• Provides an attractive alternative for obtaining pet medications in terms of convenience, price, ease of ordering and rapid home delivery.

The Leading Direct Marketer of Pet Medications Annual Sales (in millions)

SalesSix Months Ended September 30th (in millions)

For the six months ended September 30, 2018, reorder revenue increased 10.8%.

$205.6

$230.3

$0.0

$50.0

$100.0

$150.0

$200.0

$250.0

FY 2017 FY 2018

E-Commerce Annual Sales (in millions)

E-Commerce SalesSix Months Ended September 30th (in millions)

For the six months ended September 30, 2018, approximately 85% of our revenue was generated from our website.

Fast, Easy, Helpful Service With Great Savings

• Consumers generally save money from veterinarians' prices.

• Consumers enjoy the convenience of rapid home or office delivery.

• Exceptional customer care and support is our top priority.

Exceptional Customer Service

0%

25%

50%

75%

100%

Dec

-17

Mar

-18

Jun-

18

Sep-

18PETS

AVG

Net Promoter Score

PETS 81.6%

AVG 45.0% (1)

(1)NPS Benchmark Study, December 2017, www.netpromoter.com average for online shopping.

• Net Promoter Score = 81.6%

in the top 2 % of companies

• Google Seller Rating = 4.7/5.0

• Average email response time is less than 10 minutes vs 24 hours

Pet Medications

• Flea & Tick Preventatives• Heartworm Preventives• Arthritis, Thyroid, Heart, Blood Pressure• Skin, Dental, Ear, Eye Care• Vitamins & Nutritional Supplements

$69.5 Billion Pet Market in U.S.4.1% Growth in 2017

According to American Pet Products Manufacturers Association (APPMA).

$17.1

$15.1

$6.2

$2.1

$29.1

Food 3.1% Growth

Vet Care 6.7% Growth

Supplies/Medicine 2.8% Growth

Grooming/Boarding 6.2% Growth

AnimalPurchases 0% Growth

Pet Medications Market Share $5 Billion (Estimated)

According to IMS Health and NACDS Economics Dept., in human pharmaceuticals, 19% of the market is serviced by mail order/on-line channel.

58%6%

6%

30%

Veterinarians

Retailers

1-800-PetMeds

Other Mail OrderPure Plays

Sales Seasonality TrendsFiscal Year Ended March 31, 2018

29%

25%

22%

24%

1st Q EndingJune 30, $79.7 million

2nd Q EndingSeptember 30,$66.7 million

3rd Q EndingDecember 31,$60.1 million

4th Q EndingMarch 31, $67.3 million

Average Order Value

For the six months ended September 30, 2018, AOV was $89 compared to $86 for the same period the prior year.

Customer Acquisition Cost

For the six months ended September 30, 2018, CAC was $42 compared to $36 for the same period the prior year.

Competitive Strengths

• Channel leader

• “1-800-PetMeds” brand name

• Licensed pharmacy to do business in 50 states –Pharmacy verified website

• Superior service – Fast, Easy and Helpful – Most consumers do not have hard copy prescriptions. We do the work for them.

• 1,000 SKUs in stock, and 2,000 SKUs via third party

Annual Net Income(in millions)

Net IncomeSix Months Ended September 30th (in millions)

Diluted EPS(per share)

Diluted EPSSix Months Ended September 30th (per share)

For the quarter ended September 30, 2018, diluted earnings per share was $0.52 vs $0.43 for the same period the prior year.

Gross Profit Margin

For the six months ended September 30, 2018 and 2017, gross profit margin was 34.8%.

Summary Financial Data (in millions)

New Order Revenue 46.3$ 16.9% 42.9$ 17.2%Reorder Revenue 227.5$ 83.1% 206.3$ 82.8%Total Net Revenue 273.8$ 249.2$

Gross Profit 97.8$ 35.7% 79.3$ 31.8%

G&A Expenses 24.3$ 8.9% 22.8$ 9.2%Advertising Expenses 19.3$ 7.0% 17.6$ 7.1%Depreciation Expenses 2.1$ 0.8% 1.4$ 0.5%

Operating Income 52.1$ 19.0% 37.5$ 15.0%

Net Income 37.3$ 13.6% 23.8$ 9.5%

EPS - Diluted 1.82$ 1.17$

Dividends Declared 0.85$ 0.76$

FY 2018 FY 2017

Summary Financial Data (in millions)

Six Months Ended

New Order Revenue 26.3$ 16.6% 26.9$ 18.3%Reorder Revenue 132.5$ 83.4% 119.5$ 81.7%Total Net Revenue 158.8$ 146.4$

Gross Profit 55.2$ 34.8% 51.0$ 34.8%

G&A Expenses 13.1$ 8.3% 12.4$ 8.5%Advertising Expenses 12.0$ 7.6% 10.8$ 7.4%Depreciation Expenses 1.1$ 0.7% 1.1$ 0.7%

Operating Income 29.0$ 18.2% 26.7$ 18.2%

Net Income 23.3$ 14.7% 18.0$ 12.3%

EPS - Diluted 1.14$ 0.88$

Dividends Declared 0.52$ 0.40$

SEPT Q FY19 SEPT Q FY18

4 Compelling ReasonsTo invest in 1-800-PetMeds

1. Leader in its channel in an estimated $5 billion industry

2. 1-800-PetMeds brand name

3. Licensed pharmacy to conduct business in 50 states

4. Exceptional customer service and support